AXL drugs for Non-Small Cell Lung Cancer

2 tracked AXL drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the AXL page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

1 Phase 21 preclinical / unstaged

Head-to-head evidence: Ligritinib vs Mecbotamab vedotin (CAB-AXL-ADC)

The roster

← all AXL drugs